Product Documents

424B3 Prospectus Supplement 03/30/26 (TSOL)

March 31, 2026

424B3 Prospectus Supplement 03/16/26 (TDOG)

March 16, 2026

424B3 Prospectus Supplement 02/20/26 (TDOG)

February 23, 2026

424B3 Prospectus Supplement (TSOL)

February 11, 2026

424B3 Prospectus Supplement (TOXR)

January 27, 2026

Supplement #2 01/26/26 (TSOL)

January 27, 2026

Supplement #1 01/26/26 (TSOL)

January 27, 2026

Supplement 10/8/2025 (TETH)

October 9, 2025

Supplement 07/20/25 (ARKB)

August 4, 2025

Supplement 07/20/25 (TETH)

August 4, 2025

Supplement 05/13/25 (TETH)

June 10, 2025

Supplement 03/28/25 (TETH)

April 15, 2025

Supplement 11/12/24 (TETH)

April 15, 2025

Supplement 9/12/24 (TETH)

April 15, 2025

Regulatory framework and 40-Act protections

The products listed include both 33-Act Exchange-Traded Products (ETPs) and 40-Act Exchange-Traded Funds. 21shares ETPs are not registered under the Investment Company Act of 1940, as amended ("40-Act"), and therefore are not subject to the same regulations and protections as 40-Act registered ETFs and mutual funds. Crypto-related ETPs are subject to significant risk and heightened volatility. ETPs investing in spot crypto assets are not suitable for an investor who cannot afford to the loss of the entire investment. An investment in ETP is no a direct investment in any crypto currency.